DEFINITIVE PROXY STATEMENT

Company

Mosaic ImmunoEngineering Inc.

Filed

September 12, 2001

Period of Report

October 11, 2001

Accession Number

0001095811-01-504852

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →